Licensed, profitable German medical cannabis importer & wholesaler for sale on target for €9M/yr revenue
Fully licensed & profitable German medical cannabis distributor offers an integrated, EU-GDP compliant platform for immediate market access and a gateway to EU-GMP processing, on target for €9M revenue in 2025 with €10.8M projected in 2026
Listing ID:
42249812560
Licence(s) Held:
Registered Dealer of Pharmaceutical Ingredients, MedCan permit and EU-GDP Wholesaler. Medical Import Licence. EU-GMP manufacturing certification in progress.
Seeking outright divestiture of the licences and going concern business for €4.5 million o.b.o
Listing Details:
This is a fully operational, profitable medical cannabis importer & wholesaler with established distribution across the German market, the single largest and most valuable medical cannabis market in Europe.
The company is a solid revenue-generator, on target to reach €9 million in 2025, with €10.8 Million in revenue projected for 2026.
The platform provides direct, regulatory-compliant market access, leveraging established EU-GDP and EU-GMP supply chains and a trusted network of 40 global suppliers for broad-based product sourcing.
The company distributes a diverse product portfolio (+50 products across +35 strains), including its own proprietary brands.
The company is actively pending EU-GMP manufacturing certification which will provide a clear, de-risked pathway to internal processing and product manufacturing, allowing the capture of higher-margin activities.
The company is led by an experienced management team with deep roots in the German pharmaceutical and pharmacy markets.
The R&D pipeline focuses on high-value product innovation, including access to an innovative lozenge formulation and specialized oral administration solutions, securing a future competitive advantage.
The business is highly scalable, successfully managing high-volume sales (over 2.5 tonnes annually) with a minimal workforce (15 FTEs), ready for increased throughput upon capital injection.
The acquisition secures access to a patented purification technology, ensuring a proprietary, cost-efficient supply chain of pharmaceutical-grade, EU-GMP certified product starting in 2026.
This opportunity is ideal for Global Cannabis Operators, Healthcare/Pharma Players, and Investment Firms seeking immediate, de-risked entry and a high-growth platform within the regulated German and European medical cannabis markets.
42249812560
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
28971289009
Court-Approved Sale & Investment Solicitation Opportunity – Noble Growth Corp. & Noble Growth Alberta LP
Opportunity to acquire, invest in, restructure, or refinance a fully licensed cannabis cultivation, processing, branded products, and medical cannabis platform through a Court-approved Sale and Investment Solicitation Process (SISP) under CCAA. This offering provides a potential "clean slate" entry into the Canadian and international cannabis markets through a debt-free acquisition structure.
28790904174
Licensed 8,500 ft² Cannabis Cultivation & Nursery Facility on 23 Acres Near Montreal, QC for $1.7M OBO
Opportunity to acquire a fully built-out, cannabis cultivation buildings located 30 minutes east of Montreal, featuring two purpose-built cultivation and nursery buildings on 23 acres for 1.7M o.b.o
44498920359
Early-Stage UK Medical Cannabis Platform – Licensed Market Entry Opportunity
Unique opportunity to invest in a pre-operational UK medical cannabis platform being established through a structured regulatory and licensing pathway, led by an experienced sector operator and set to operate all steps from import to patient.